Introduction
Refractory epilepsy is associated with cognitive and social impairment, poor quality of life and increased risk of death. However, natural history of established refractory epilepsy is not well known. The objective of our study was to find out the long term prognosis (seizure and social outcome) of patients with refractory epilepsy who were evaluated in our epilepsy unit but did not undergo epilepsy surgery.
Methods
We performed a retrospective chart review and a telephone survey of patients who underwent presurgical evaluation in our Unit from 1998 until 2004 but did not have epilepsy surgery afterwards. We excluded patients with a previous diagnosis of drug resistant focal epilepsies who turned out to be generalized epilepsies and generalized epilepsies with known bad prognosis (for example patients with Lennox-Gastaut syndrome). From chart review we assessed: age at seizure onset, type of epilepsy, etiology, lesion on the MRI, seizure frequency when presurgical evaluation was performed, and reason why surgery was not performed.
Once the patients were contacted by phone and permission was given to participate in the study, we inquired about current seizure frequency, AED use, overall impression of change (better, worse or similar respect to the time they were evaluated), and current level of satisfaction with life, rated by the patients on a 5-point global categorical scale. We also asked about marital and employment situation, neurological and psychiatric follow up.
Descriptive statistics for continuous variables, parametrical and non parametrical tests were used.
Results
Of a total population of 110 patients, we were able to contact 84 patients or families by phone; the rest could not be found, likely due to change of address or telephone. All patients we contacted agreed to participate in the study. In 4 patients who had died, families or caregivers agreed to provide information about circumstances surrounding death.
Mean age was 40.2 years (20-74); mean age at seizure onset was 12.05 years (1-57); median follow up since presurgical evaluation was performed was 6.7 years (2-11.1 years). Most patients had focal (temporal and extratemporal) epilepsy. Demographic and epilepsy features of the 26 patients who could not be located did not differ from the 84 patients included in the study. The data is summarized in Table 1 . Little is known about the long term prognosis of refractory epilepsy patients who do not undergo epilepsy surgery. We performed a telephone survey and chart review of patients who underwent presurgical evaluation in our Unit but did not have surgery, from 1998 until 2004. We contacted 84 patients; mean follow-up was 6.7 years. Four patients (4.7%) had died, presumably of SUDEP. Ten patients (13.1%) were seizure free. In most patients with seizures, frequency remained stable (24/80, 30%) or had decreased by 50% (26 patients, 30.9%). Most patients (69, 86.2%) believed their health was similar or better respect to the moment they underwent presurgical evaluation. Employment situation was stable in 64/80 patients (80%), but 11 had received new disability wages. Family situation was also generally unchanged (69/80 patients, 86.2%). Most patients were not taking antidepressants. Seizure free patients scored higher in satisfaction with life. This information can be used to counsel refractory patients.
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Among the patients included in the study, the reasons for not having epilepsy surgery were mainly multifocal seizure onset (29 patients, 34.9% patients) or non conclusive presurgical evaluation (36 patients, 42.8%). Less often, surgery was not offered due to significant risk to eloquent cortex or the patient rejected surgical treatment (Table 1) .
Four out of 84 (4.7%) patients had died. All of them had been found dead without clear explanation; exitus was attributed to sudden death in epilepsy (SUDEP). Of those 4 patients, 3 had extratemporal and 1 had temporal lobe epilepsy. The etiology was cryptogenic in 3 and symptomatic in 1. Patients who died had lower seizure frequency (median: 3 seizures a month) than patients who were alive (median: 10 seizures a month) when presurgical evaluation was performed. There were no differences regarding age or age at seizure onset.
Median monthly frequency of seizures when patients were admitted to the EMU was 8.5 . Median frequency when the study was performed was 4 a month (0-180). Forty seven patients (58.8%) were seen regularly by epileptologists, and 33 (41.3%) by general neurologists. Ten patients (13.1%) had been seizure free when they were contacted and had been seizure free for at least the previous 6 months. Seizure freedom was temporarily related to the use of new antiepileptic drugs in 2 patients (pregabalin in 1 patient and topiramate in another). In the rest, seizure freedom was related to the use of ''classical'' antiepileptic drugs (phenytoin in 1 patient and clobazam in 2 patients) or occurred without clear temporal relationship to changes in medications (5 patients). Eight of these patients had focal epilepsy (1 temporal, 7 extratemporal) and 2 had generalized epilepsy.
The effect of the follow-up on the likelihood of achieving seizure freedom was assessed by means of parametric and nonparametric tests and no statistically significant effect was detected (t-test, p = 0.377; Mann-Whitney test, p = 0.4494). We also assessed the effect on a logistic model using time as a continuous variable (p = 0.375) as well as tertiles (signification test p = 0.628; trend test p = 0.414) and quartiles (signification test p = 0.929; trend test p = 0.547). The results of this analysis together with the small differences (0.76 years in medians and 0.77 years in means) suggest that there was no relevant effect between both groups due to the follow-up time.
Seizure and social outcome is summarized in Table 2 . Seventy out of eighty alive patients (87.5%) still had seizures. Seizure frequency had decreased by 50% in 26 patients (32.5%); of those, 13 patients (16.2%) had a 75% reduction. Seizure frequency remained stable or had changed by less than 50% in 31 patients (38.5%). Seizure frequency had increased by 50% in 6 patients (7.5%) and had increased by 100% in 7 patients (8.7%). Subjectively, 40 (50%) patients felt their health was better than at the time they had been admitted, 29 patients (36.3%) felt it was similar and 11 patients (13.8%) felt it was worse. At the time of admission, 33 patients were married or lived with a stable couple, 45 patients were single and 2 patients were divorced. When we contacted them, 34 patients were married or lived with a stable couple, 39 were single and 7 patients were divorced. Family situation had ''improved'' in 6 patients who got married and ''worsened'' in 5 patients who got divorced. Family situation remained stable in most patients (69, 86.2%).
When they were admitted, 38 patients were employed, 19 patients were unemployed, 20 patients received disability wages and 3 patients were housewives. When we called them, 26 patients were employed, 19 patients were unemployed, the number of patients receiving disability wages had increased (31 patients) and 4 patients were housewives. Only 3 patients got a new job during the follow up, employment situation had worsened (disability or unemployment) in 16 patients and remained stable in 64. Most patients (65, 81.2%) were not taking antidepressant or antipsychotic medications when the study was performed. Sixteen patients had regular psychiatric follow up and 64 patients did not.
In a global categorical scale ranging from 1 (very low satisfaction) to 5 (high satisfaction), 18 patients (22.5%) rated their global satisfaction with life as 1 or 2, 29 patients (36.25%) as 3, and 33 patients (41.25%) as 4 or 5. Higher scores seemed to be associated with seizure freedom; median score in the seizure free group was 5, being 3 in the group with persisting seizures (data not shown).
Discussion
Patients with drug resistant epilepsy who turn out not to be good surgical candidates often ask their epileptologists about long term prognosis. Available information regarding long term outcome and consequences of refractory epilepsy may be discouraging.
1,2 However, in a previous study including 34 patients who were evaluated for epilepsy surgery and did not have surgery, with a follow up of more than 4 years after presurgical evaluation, up to 21% were found to be seizure free. 3 Seizure freedom in our series was slightly lower, 13.1%, similar to the percentage reported in other studies which included patients with refractory epilepsy prospectively followed in a tertiary center. 4 Due to the nature of the study, we could not assess the influence of the length of the follow up in the likelihood of achieving remission using survival curves and this is a serious limitation of our study, but using other statistical tests we could not find such an effect in our series. Seizure remission seems to be ''spontaneous'' in some patients. This has been previously described in other studies and may point to a relapsing remitting course not always influenced by treatment. However, and given the fact that in some patients remission is temporarily related to an antiepileptic drug trial (either ''classical'' or ''new''), it is reasonable that most antiepileptic drugs are tried rationally in drug resistant patients, always balancing seizure control against possible side effects. 5 Our study also shows that seizure frequency tends to remain stable, and only a minority of patients experience a significant increase; most perceive their general health as similar or better respect to the moment they were admitted in the Unit. As intractability may follow long periods of seizure freedom, many refractory patients are afraid of having more frequent and more severe seizures in the future. This study shows that it is not usually the case.
We found out that 4 out of 84 patients had been found dead, presumably of SUDEP. Of course, some of these patients may have died of other medical conditions; however it confirms the increased mortality in this population and reinforces the need for counselling in patients felt to be at risk. 6 Refractory epilepsy is associated with psychosocial dysfunction. Our study was not designed to address all aspects of social functioning; however it shows that during the follow up period, family situation remained stable in most patients and work situation worsened, with more patients receiving disability wages over time (as expected in a chronic disease). It is known that even after epilepsy surgery, employment gains are modest and seen mainly in the seizure free patients. 7 The fact that most patients were not taking antidepressant drugs or had regular psychiatric follow does not necessarily imply lack of depression in this population; it is known that this condition remains undiagnosed in many patients. Unfortunately, a telephone survey does not allow adequate assessment of mood, cognitive changes or adverse effects of medications, all of them known to have a significant impact on quality of life, which could not be properly assessed either. 8, 9 Using a rough system of a 5 point categorical scale, satisfaction with life seemed to be higher in seizure free patients, as previously reported. 10, 11 In summary, our study shows that seizure frequency in patients with drug resistant epilepsy tends to remain stable or improve over time; a minority of patients have significant worsening or become seizure free. This may happen spontaneously or in temporal relationship with a new antiepileptic drug trial. Family situation generally stays similar, and more patients will be on disability wages over time. Most patients included in this study felt that their health was similar or better respect to the moment they undewerwent presurgical evaluation. This information may be useful to counsel drug resistant patients who cannot undergo epilepsy surgery.
